Research Topics
| Yoshihiko MurataSummaryAffiliation: University of Rochester Country: USA Publications
| Collaborators |
Detail Information
Publications
Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment proteinYoshihiko Murata
Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry and Infectious Diseases Unit, Rochester General Hospital, 601 Elmwood Avenue Box 689, Rochester, NY 14642, USA Yoshihiko
Vaccine 28:6242-6. 2010..Our results have implications for RSV G-based serological diagnostics and vaccine development...
Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment proteinYoshihiko Murata
Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 689, Rochester, NY 14642, USA
Clin Vaccine Immunol 17:695-7. 2010..In approximately 40% of hospitalized and outpatient adults infected with RSV subtype A, these contiguous residues are the target of > or =4-fold increases in IgG response between acute- and convalescent-phase sera...
Respiratory syncytial virus infection in adultsYoshihiko Murata
Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester General Hospital, New York, USA
Antivir Ther 12:659-70. 2007..Vaccines against RSV remain an unachieved goal. Promising new agents that inhibit the virus-cell fusion, cell-cell fusion, or viral gene expression are currently in development...
Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeresYoshihiko Murata
Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
Virol J 6:81. 2009..We sought to utilize HPV L1 capsomeres as a vaccine platform by engineering heterologous epitopes within L1 derivatives deleted for h4 domain...
Respiratory syncytial virus vaccine developmentYoshihiko Murata
Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Clin Lab Med 29:725-39. 2009..The scientific rationale, preclinical testing, and clinical development of each of these approaches are reviewed...
Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in miceYoshihiko Murata
Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
Vaccine 30:5382-8. 2012..Our results have implications for RSV G-based serological assays as well as prophylactic immunotherapy and RSV vaccine development...
Pulmonary complications of interpandemic influenza A in hospitalized adultsYoshihiko Murata
Department of Medicine, University of Rochester School of Medicine and Dentistry and Infectious Diseases Unit, Department of Medicine, Rochester General Hospital, Rochester, NY 14621, USA
J Infect Dis 195:1029-37. 2007....
Respiratory syncytial virus infection in adultsYoshihiko Murata
Division of Infectious Diseases, Department of Medicine, University of Rochester School of Medicine and Dentistry, Infectious Diseases Unit, Rochester General Hospital, Rochester, New York 14621, USA
Curr Opin Pulm Med 14:235-40. 2008..Respiratory syncytial virus has increasingly been recognized as a clinically significant cause of respiratory tract infections in adults, especially among the elderly and the immunocompromised...
